Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  1998-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABBI.1998.0798PMID 9735159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Complements C3 and C5 in the Phagocytosis of Liposomes by Human Neutrophils

  2004cited by this paper
• Polymers as Biomaterials

  1999cited by this paper
• The complement system in liposome clearance: Can complement deposition be inhibited?

  1998cited by this paper
• Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.

  1997cited by this paper
• Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight.

  1996cited by this paper
• Preparation of characterization of poly(ethylene glycol) vinyl sulfone.

  1996cited by this paper
• Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine.

  1996cited by this paper
• Influence of dose on liposome clearance: critical role of blood proteins.

  1996cited by this paper
• Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis.

  1996cited by this paper
• Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin.

  1995cited by this paper
• Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes

  1994cited by this paper
• Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles.

  1994cited by this paper
• Kinetic modelling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro

  1994cited by this paper
• Studies on the antiatherogenic properties of liposomes

  1994cited by this paper
• Liposome-complement interactions in rat serum: implications for liposome survival studies.

  1994cited by this paper
• The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ.

  1994cited by this paper
• Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.

  1994cited by this paper
• Liposome-induced activation of the classical complement pathway does not require immunoglobulin.

  1994cited by this paper
• Complement-dependent phagocytosis of liposomes.

  1993cited by this paper
• Molecular mechanism of the lipid vesicle longevity in vivo.

  1993cited by this paper
• Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion.

  1993cited by this paper
• Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen.

  1992cited by this paper
• Poly(Ethylene Glycol) Chemistry Biotechnical and Biomedical Applications

  1992cited by this paper
• Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.

  1992cited by this paper
• Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).

  1992cited by this paper
• Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.

  1992cited by this paper
• Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium

  1992cited by this paper
• The role of surface charge and hydrophilic groups on liposome clearance in vivo.

  1992cited by this paper
• Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size.

  1991cited by this paper
• Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma.

  1991cited by this paper
• The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.

  1991cited by this paper
• Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.

  1991cited by this paper
• Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.

  1991cited by this paper
• Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.

  1991cited by this paper
• Liposomes for the sustained drug release in vivo.

  1990cited by this paper
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

  1990cited by this paper
• Liposomes with entrapped doxorubicin exhibit extended blood residence times.

  1990cited by this paper
• Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.

  1989cited by this paper
• Enhancement of the binding of C1q to immune complexes by polyethylene glycol.

  1988cited by this paper
• Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

  1988cited by this paper
• Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential.

  1985cited by this paper
• Antibody-independent activation of C1, the first component of complement, by cardiolipin.

  1985cited by this paper
• The pharmacological efficacy of a rigid non-phospholipid liposome drug delivery system.

  1984cited by this paper
• Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.

  1983cited by this paper
• A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin.

  1983cited by this paper
• Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components.

  1982cited by this paper
• Purification and radiolabeling of human C1q.

  1981cited by this paper
• Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.

  1977cited by this paper
• Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

  1977cited by this paper
• The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.

  1975cited by this paper
• Lesions due to Complement in Lipid Membranes

  1971cited by this paper
• Electrophoretic pattern of and amino acid incorporation in vitro into the insoluble mitochondrial protein of neurospora crassa wild type and mi‐1 mutant

  1968cited by this paper
• THE COLORIMETRIC DETERMINATION OF PHOSPHORUS

  1925cited by this paper

• A FRET-based toolkit for quantifying lipid incorporation into nanoparticles.

  2026cites this paper
• Innovative Lipid-Based Nanobiotechnology: Diagnostics and Medicine.

  2026cites this paper
• A review on protein corona formation on nanoparticles and prediction of its composition using artificial intelligence tools.

  2025cites this paper
• In Vivo Delivery Processes and Development Strategies of Lipid Nanoparticles

  2024cites this paper
• Stability of Liposomal Membrane of Hemoglobin-Vesicles (Artificial Red Cells) for Over Years of Storage Evaluated Using Liquid Chromatography-Mass Spectrometry.

  2024cites this paper
• Controlling the Biological Fate of Liposomal Spherical Nucleic Acids Using Tunable Polyethylene Glycol Shells.

  2021cites this paper
• Synthesis of poly(2-methacryloyloxyethyl phosphorylcholine)-conjugated lipids and their characterization and surface properties of modified liposomes for protein interactions.

  2021cites this paper
• Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions.

  2021cites this paper
• The Combination of Morphology and Surface Chemistry Defines the Immunological Identity of Nanocarriers in Human Blood

  2021cites this paper
• Microfluidic production of protein loaded chimeric stealth liposomes.

  2020cites this paper
• The structural fate of lipid nanoparticles in the extracellular matrix.

  2020cites this paper
• Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes.

  2020cites this paper
• Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery

  2020cites this paper
• Effects of the molecular weight and molar ratio of poly(2-ethyl-2-oxazoline)-based lipid on the pH sensitivity, stability, and antitumor efficacy of liposomes

  2020cites this paper
• Role of the complement cascade in the biological fate of liposomes in rodents.

  2020cites this paper
• Building Blocks to Design Liposomal Delivery Systems

  2020cites this paper
• Liposome and immune system interplay: Challenges and potentials.

  2019cites this paper
• Polymersomes.

  2019cites this paper
• Nanomedicine and Drug Delivery Systems in Overcoming Resistance to Targeted Therapy

  2019cites this paper
• Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes

  2019cites this paper
• Drug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells.

  2019cites this paper
• Chapter 2 Nanoparticle and Protein Corona

  2019cites this paper
• PEG‐Lipid Post Insertion into Drug Delivery Liposomes Quantified at the Single Liposome Level

  2019cites this paper
• A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy

  2018cites this paper
• Principles of Nanomedicine

  2017cites this paper
• A Radiopharmaceutical Kit to Prepare Unilamellar Porphysome Nanovesicles with Positron-emitting Radionuclide Copper-64 for Dual-modal Positron Emission Tomography and Fluorescence Imaging

  2017cites this paper
• Recommendations of the Oligonucleotide Safety Working Group's Formulated Oligonucleotide Subcommittee for the Safety Assessment of Formulated Oligonucleotide-Based Therapeutics

  2017cites this paper
• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

  2016cites this paper
• Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation.

  2016cites this paper
• Influence of membrane surface charge on adsorption of complement proteins onto supported lipid bilayers.

  2016cites this paper
• Cationic liposome–nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing

  2016cites this paper
• DRUG DELIVERY TO BRAIN AND BONE MARROW: A REVIEW

  2016cites this paper
• Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.

  2016cites this paper
• Liposome-Encapsulated Hemoglobin as an Artificial Oxygen Carrier

  2016cites this paper
• Pharmacokinetics and tissue distribution study of 16-dehydropregnenolone liposome in female mice after intravenous administration

  2016cites this paper
• Nano Liposomes Labeled with 99mTc-HMPAO, a Novel Agent for Blood Pool Imaging

  2015cites this paper
• Molecular Modeling as a Tool to Understand the Role of Poly(Ethylene) Glycol in Drug Delivery

  2015cites this paper
• Biodistribution and delivery efficiency of unmodified tumor-derived exosomes.

  2015cites this paper
• Self-assembled drug delivery systems. Part 8: In vitro/in vivo studies of the nanoassemblies of cholesteryl-phosphonyl gemcitabine.

  2015cites this paper
• Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems.

  2014cites this paper
• EPR: Evidence and fallacy.

  2014cites this paper
• Photodynamic therapy: one step ahead with self-assembled nanoparticles.

  2014cites this paper
• Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy

  2014cites this paper
• Complement activation by PEGylated liposomes containing prednisolone.

  2013influential citation
• Influence of covalently conjugated monodisperse polyethylene glycol chains on in vitro properties ofsiRNA oligonucleotides

  2013cites this paper
• Enhanced tumor accumulation and cellular uptake of liposomes modified with ether-bond linked cholesterol derivatives.

  2013cites this paper
• Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.

  2013cites this paper
• Protein-Based Blood Substitutes: Recent Attempts at Controlling Pro-Oxidant Reactivity With and Beyond Hemoglobin

  2013cites this paper
• Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs

  2013cites this paper
• Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

  2013cites this paper
• Applications of antibiofouling PEG-coating in electrochemical biosensors for determination of glucose in whole blood

  2013cites this paper
• Nanoparticle and Protein Corona

  2013cites this paper
• Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

  2013cites this paper
• Biocompatibility of Hemoglobin Vesicles, a Cellular-Type Artificial Oxygen Carrier, on Blood Cells and Plasma Proteins In Vitro and In Vivo

  2013cites this paper
• Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers

  2013cites this paper
• Recent advances in anogenital antiretroviral microbicides and multimodal delivery systems.

  2012cites this paper
• Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.

  2012cites this paper
• Toxicological profile of therapeutic nanodelivery systems.

  2012cites this paper
• Vergleichende Untersuchungen zur Wirkung verschiedener Liposomenformulierungen auf das humane und murine Komplementsystem

  2012cites this paper
• Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs.

  2012cites this paper
• Exosome mimetics: a novel class of drug delivery systems

  2012cites this paper
• Nanoparticulate targeted drug delivery using peptides and proteins

  2012cites this paper
• Development and Stability Studies of Novel Liposomal Vancomycin Formulations

  2012cites this paper
• Handbook of Immunological Properties of Engineered Nanomaterials Chapter 11 Complement Activation

  2012cites this paper
• The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides.

  2011cites this paper
• Engineering Cellular Hemoglobin-Based Oxygen Carriers For Use In Transfusion Medicine

  2011cites this paper
• Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems

  2011cites this paper
• Transformation from Multilamellar to Unilamellar Vesicles by Addition of a Cationic Lipid to PEGylated Liposomes Explored with Synchrotron Small Angle X-ray Scattering

  2011cites this paper
• CH(50): a revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction.

  2011cites this paper
• Improvement of Graft Survival by Surface Modification With Poly(ethylene glycol)-Lipid and Urokinase in Intraportal Islet Transplantation

  2011cites this paper
• Large scale production of vesicles by hollow fiber extrusion: a novel method for generating polymersome encapsulated hemoglobin dispersions.

  2010cites this paper
• Liposomes and Drug Delivery

  2010cites this paper
• Adsorption of amphiphilic hyperbranched polyglycerol derivatives onto human red blood cells.

  2010cites this paper
• Surface Modification of Islets With PEG-Lipid for Improvement of Graft Survival in Intraportal Transplantation

  2009cites this paper
• The encapsulation of DNA molecules within biomimetic lipid nanocapsules.

  2009cites this paper
• Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities.

  2009cites this paper
• Receptor-Specific Targeting with Liposomes In Vitro Based on Sterol-PEG1300 Anchors

  2009cites this paper
• Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.

  2009cites this paper
• Cationic liposome mediated targeted gene delivery with and without pegylated accessories.

  2009cites this paper
• Lipid-based systemic delivery of siRNA.

  2009cites this paper
• Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions

  2009cites this paper
• Accelerated Blood Clearance of PEGylated Liposomes after Second Injection

  2008cites this paper
• Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: effect of the structure of acidic groups.

  2008cites this paper
• Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26.

  2008influential citation
• The molecular basis of complement activation by model nanomedicines

  2008cites this paper
• [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].

  2008cites this paper
• Physicochemical Characterization and Study of in vitro Interactions of pH-sensitive Liposomes with the Complement System

  2008cites this paper
• Liposome-Mediated Triggering of Complement Cascade

  2008cites this paper
• Universal red blood cells

  2008cites this paper
• Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides.

  2008cites this paper
• ポリエチレングリコール修飾リポソーム投与時に生ずる Accelerated Blood Clearance (ABC）現象

  2008cites this paper
• Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.

  2008cites this paper
• Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes.

  2007cites this paper
• Lipid-Based Nanoparticulate Drug Delivery Systems

  2007cites this paper
• Effect of Liposome Characteristics and Dose on the Pharmacokinetics of Liposomes Coated with Poly(amino acid)s

  2007cites this paper
• Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors.

  2007cites this paper
• Effect of headgroup on DNA-cationic surfactant interactions.

  2007cites this paper
• Liposomal Drug Delivery

  2007cites this paper
• Targeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrin

  2007cites this paper
• Solution to the problems of acellular hemoglobins by encapsulation and the intrinsic issues of hemoglobin vesicles as a molecular assembly

  2007cites this paper